Kayser, S. and Schlenk, R. F. (2026) “All patients with AML and FLT3-ITD should be transplanted in first remission. Also in the era of tyrosine kinase inhibitors? – the PRO”, Haematologica. Pavia, Italy, 111(4), pp. 1149-1152. doi: 10.3324/haematol.2025.288785.